Open AccessTRANSFERRIN ENSURES SURVIVAL OF OVARIAN CARCINOMA CELLS SUBJECTED TO DEFEROXAMINE, TNFa, FasL, TRAIL or MYC -ACTIVATION
Author(s) -
Georg Rosenberger,
Michael Grusch,
Gerhard Fuhrmann,
Katharina Leuhuber,
Doris Polgar,
Georg Krupitza
Publication year - 2001
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2001.23.192
Subject(s) - transferrin , deferoxamine , ovarian carcinoma , tumor necrosis factor alpha , cancer research , fas ligand , apoptosis , medicine , ovarian cancer , immunology , biology , chemistry , cancer , biochemistry , programmed cell death
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom